Sarah E. Nash, Director at MERRIMACK PHARMACEUTICALS INC (MACK), bought 15,000 shares at $6.79 ($102K) on 2014-05-07, disclosed to the SEC on 2014-05-09.
Open-market purchase of $102k MACK by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BLKB | SELL | 2024-11-13 | $260K | — | Filing → |
| BLKB | SELL | 2024-08-09 | $491K | — | Filing → |
| BBWI | SELL | 2024-06-20 | $2.0M | — | Filing → |